Literature DB >> 11441062

Cutting edge: IFN-inducible ELR- CXC chemokines display defensin-like antimicrobial activity.

A M Cole1, T Ganz, A M Liese, M D Burdick, L Liu, R M Strieter.   

Abstract

Recent reports highlighted the chemotactic activities of antimicrobial peptide defensins whose structure, charge, and size resemble chemokines. By assaying representative members of the four known families of chemokines we explored the obverse: whether some chemokines exert antimicrobial activity. In a radial diffusion assay, only recombinant monokine induced by IFN-gamma (MIG/CXCL9), IFN-gamma-inducible protein of 10 kDa (IP-10/CXCL10), and IFN-inducible T cell alpha chemoattractant (I-TAC/CXCL11), members of the IFN-gamma-inducible tripeptide motif Glu-Leu-Arg (ELR)(-) CXC chemokines, were antimicrobial against Escherichia coli and Listeria monocytogenes. Similar to human defensins, antimicrobial activities of the chemokines were inhibited by 50 and 100 mM NaCl. The concentration of MIG/CXCL9 and IP-10/CXCL10 released from IFN-gamma-stimulated PBMC in 24 h were, respectively, 35- and 28-fold higher than from unstimulated cells. Additionally, the amounts of chemokines released per monocyte suggest that, in tissues with mononuclear cell infiltration, IFN-gamma-inducible chemokines may reach concentrations necessary for microbicidal activity. IFN-gamma-inducible chemokines may directly inactivate microbes before attracting other host defense cells to the area of infection.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11441062     DOI: 10.4049/jimmunol.167.2.623

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  130 in total

Review 1.  Chemokines meet defensins: the merging concepts of chemoattractants and antimicrobial peptides in host defense.

Authors:  Manuela Dürr; Andreas Peschel
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

Review 2.  Antimicrobial peptides: current status and therapeutic potential.

Authors:  Andreas R Koczulla; Robert Bals
Journal:  Drugs       Date:  2003       Impact factor: 9.546

3.  Multidimensional signatures in antimicrobial peptides.

Authors:  Nannette Y Yount; Michael R Yeaman
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-26       Impact factor: 11.205

4.  Midkine and pleiotrophin have bactericidal properties: preserved antibacterial activity in a family of heparin-binding growth factors during evolution.

Authors:  Sara L Svensson; Mukesh Pasupuleti; Björn Walse; Martin Malmsten; Matthias Mörgelin; Camilla Sjögren; Anders I Olin; Mattias Collin; Artur Schmidtchen; Ruth Palmer; Arne Egesten
Journal:  J Biol Chem       Date:  2010-03-22       Impact factor: 5.157

5.  Citrullination and proteolytic processing of chemokines by Porphyromonas gingivalis.

Authors:  Eva A V Moelants; Gitte Loozen; Anneleen Mortier; Erik Martens; Ghislain Opdenakker; Danuta Mizgalska; Borys Szmigielski; Jan Potempa; Jo Van Damme; Wim Teughels; Paul Proost
Journal:  Infect Immun       Date:  2014-03-31       Impact factor: 3.441

6.  Interleukin-8-derived peptide has antibacterial activity.

Authors:  Ase Björstad; Huamei Fu; Anna Karlsson; Claes Dahlgren; Johan Bylund
Journal:  Antimicrob Agents Chemother       Date:  2005-09       Impact factor: 5.191

7.  Targeting the gut barrier for the treatment of alcoholic liver disease.

Authors:  Zhanxiang Zhou; Wei Zhong
Journal:  Liver Res       Date:  2017-12

8.  Maternal serum concentrations of the chemokine CXCL10/IP-10 are elevated in acute pyelonephritis during pregnancy.

Authors:  Francesca Gotsch; Roberto Romero; Jimmy Espinoza; Juan Pedro Kusanovic; Shali Mazaki-Tovi; Offer Erez; Nandor Gabor Than; Samuel Edwin; Moshe Mazor; Bo Hyan Yoon; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2007-10

9.  Antimicrobial effects of interferon-inducible CXC chemokines against Bacillus anthracis spores and bacilli.

Authors:  Matthew A Crawford; Yinghua Zhu; Candace S Green; Marie D Burdick; Patrick Sanz; Farhang Alem; Alison D O'Brien; Borna Mehrad; Robert M Strieter; Molly A Hughes
Journal:  Infect Immun       Date:  2009-01-29       Impact factor: 3.441

10.  Suppression of T-cell chemokines by Porphyromonas gingivalis.

Authors:  Catherine E Jauregui; Qian Wang; Christopher J Wright; Hiroki Takeuchi; Silvia M Uriarte; Richard J Lamont
Journal:  Infect Immun       Date:  2013-04-15       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.